高级搜索
张文庆, 吴菁, 谢地, 史雪聪, 胡汉昆. 临床新兴抗肿瘤治疗方法发展概述[J]. 肿瘤防治研究, 2022, 49(3): 176-181. DOI: 10.3971/j.issn.1000-8578.2022.21.1034
引用本文: 张文庆, 吴菁, 谢地, 史雪聪, 胡汉昆. 临床新兴抗肿瘤治疗方法发展概述[J]. 肿瘤防治研究, 2022, 49(3): 176-181. DOI: 10.3971/j.issn.1000-8578.2022.21.1034
ZHANG Wenqing, WU Jing, XIE Di, SHI Xuecong, HU Hankun. Review of Development of Emerging Clinical Antitumor Therapeutics[J]. Cancer Research on Prevention and Treatment, 2022, 49(3): 176-181. DOI: 10.3971/j.issn.1000-8578.2022.21.1034
Citation: ZHANG Wenqing, WU Jing, XIE Di, SHI Xuecong, HU Hankun. Review of Development of Emerging Clinical Antitumor Therapeutics[J]. Cancer Research on Prevention and Treatment, 2022, 49(3): 176-181. DOI: 10.3971/j.issn.1000-8578.2022.21.1034

临床新兴抗肿瘤治疗方法发展概述

Review of Development of Emerging Clinical Antitumor Therapeutics

  • 摘要: 近年来随着肿瘤治疗方法不断进步,越来越多的新兴抗肿瘤药物获批上市,投入临床使用,此外一些处于临床试验中的治疗方法如基因疗法等也在不断取得新突破。本文主要对近年来临床上使用的新兴抗肿瘤治疗方法以及一些疗效显著、有望获批上市的抗肿瘤治疗方法作简要介绍。

     

    Abstract: With the continuous progress of tumor treatment methods in recent years, more and more emerging antitumor drugs have been approved to market and put into clinical use. In addition, some treatments that are in clinical trials such as gene therapy are also continuously making new breakthroughs. In this review, we mainly give a brief introduction to the novel antineoplastic therapies that have been clinically used in recent years, as well as the ones with remarkable efficacy and are expected to be approved for marketing.

     

/

返回文章
返回